| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Di | Tecnotree in verschiedenen Gartner-Studien für 2025 erwähnt | 189 | Tecnotree ist ein 5G-fähiger Anbieter von digitalen Business Support Systemen (BSS) mit fortschrittlichen KI-/ML-Fähigkeiten und Multi-Cloud-Erweiterbarkeit. Das Unternehmen wurde in dreizehn Gartner-Studien... ► Artikel lesen | ||
| Di | Rapid Medical Completes Enrollment in DISTALS Trial Evaluating TIGERTRIEVER 13 for Distal Vessel Occlusions | 224 | The milestone reflects growing evidence for distal-specific thrombectomy solutions and is reinforced by interim findings that confirmed no safety concerns with TIGERTRIEVER 13. Rapid Medical... ► Artikel lesen | ||
| Di | Suzano Launches Nature Strategy and Reinforces the Strategic Importance of Biodiversity Conservation to the Business | 274 | This initiative brings together science and stakeholder collaboration to drive solutions to biodiversity challenges at scale
Suzano, the world's largest pulp producer, has launched its Nature Strategy... ► Artikel lesen | ||
| Di | Sysdig Expands Global Footprint in India with the Launch of its Fifth R&D Site | 445 | Following rapid customer adoption of Sysdig Sage AI and 158% NRR across APJ in FY26, the company moves to increase R&D headcount by nearly 20%
Sysdig, the leader in real-time AI cloud defense,... ► Artikel lesen | ||
| Di | Testing Made Smarter: Nissan Technical Centre Europe and Sonatus Deliver Cutting-Edge AI Tools to Accelerate Vehicle Development | 191 | Nissan Technical Centre Europe (NTCE) and Sonatus enter development partnership to integrate AI tools to transform vehicle testing programme
Harvesting onboard vehicle data, AI tools can... ► Artikel lesen | ||
| Di | Mark43 2026 Trends Report Reveals Shift Toward AI With Human Oversight and Clear Opportunities to Modernize Public Safety Tech | 301 | Mark43, the leading cloud-native public safety operations platform, today announced the results of a national survey of U.S. first responders and law enforcement, along with complementary perspectives... ► Artikel lesen | ||
| Di | ITA Group Expands Global Event Capabilities With Two European Acquisitions | 157 | Engagement solutions leader acquires C2events in England and Daymakers in the Netherlands, strengthening their ability to deliver locally managed experiences worldwide
ITA Group, a global leader... ► Artikel lesen | ||
| Di | Andersen Global Strengthens Valuation Capabilities in Asia Pacific with ETC | 139 | Andersen Global continues to expand its presence in Asia Pacific through a Collaboration Agreement with Edmund Tie Company (ETC), a full-service real estate advisory firm headquartered in Singapore.
Established... ► Artikel lesen | ||
| Di | Interactive Brokers erweitert Marktzugang mit Aktien aus den Vereinigten Arabischen Emiraten | 170 | Interactive Brokers (Nasdaq: IBKR), ein automatisierter globaler elektronischer Broker, gab heute die Einführung von Aktien aus den Vereinigten Arabischen Emiraten (VAE) über zwei führende Börsen... ► Artikel lesen | ||
| Di | Indero Named Best Employer by Mercer | 153 | Indero, a global CRO specializing in dermatology and rheumatology, has been honored by Mercer, recognizing its excellence as a Best Employer. Indero is proud of its long-term commitment to building... ► Artikel lesen | ||
| Di | Clearwater Analytics: CWAN 2026 Outlook: Data-Driven Analysis Leveraging Institutional Assets Points to a Resilient U.S. Economy | 254 | New CWAN Duration Activity Index (CDAI) reveals how institutional investors are tactically positioning their portfolios ahead of next year Clearwater Analytics (NYSE: CWAN), the most comprehensive... ► Artikel lesen | ||
| Di | Sensormatic Solutions AI-Enabled Sensor and Video Technologies Power Store Guest Behaviors Analytics | 160 | Retailers can optimize staffing, promotions, merchandising and more through insights provided by Orbit AI sensors and Video AI cameras to maximize profitability, reduce risk and enhance shopper... ► Artikel lesen | ||
| Di | Indero von Mercer als bester Arbeitgeber ausgezeichnet | 139 | Indero, ein weltweit tätiges Auftragsforschungsinstitut mit Spezialisierung auf Dermatologie und Rheumatologie, wurde von Mercer für seine herausragenden Leistungen als bester Arbeitgeber ausgezeichnet.... ► Artikel lesen | ||
| Di | Motive Launches AI-powered Repeated Lane Swerving Detection and Other New Breakthrough AI Capabilities to Help Prevent Collisions | 161 | New AI models for lane swerving, smoking, and forward parking identify early signs of distracted and fatigued driving marking a major advancement in proactive road-safety technology Motive, the... ► Artikel lesen | ||
| Di | Phillips Medisize Highlights Inhaled Drug Delivery Device Platforms and Scientific Insights at DDL 2025 | 187 | Acquisition of Vectura strengthened inhalation capabilities, driving innovation and portfolio expansion in less than one year
Podium and poster presentations share research insights into... ► Artikel lesen | ||
| Di | LRN Corporation: LRN Appoints Bob Lemmond as Chief Executive Office | 166 | Accomplished information-services and governance executive to expand LRN's global impact in ethics, compliance, and principled performance LRN Corporation, a global leader in ethics and compliance... ► Artikel lesen | ||
| Di | CytoAgents, Inc.: CytoAgents to Present New CTO1681 Data at the ESMO Immuno-Oncology Congress 2025 | 168 | CytoAgents, Inc., a clinical-stage biotechnology company developing CTO1681, a novel, steroid-sparing inhibitor of prostaglandin-mediated inflammation announced today that data from two of its Investigational... ► Artikel lesen | ||
| Di | Medincell's Partner Teva Pharmaceuticals Announces the New Drug Application1 Submission to U.S. FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749 / mdc-TJK) for the Once-Monthly Treatment of Schizophrenia in Adults | 192 | Regulatory News:
Medincell (Paris:MEDCL):
Olanzapine long-acting injectable (LAI) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation, for a broad... ► Artikel lesen | ||
| Di | DataXstream LLC: Gulf Oil wählt das OMS+-Portal von DataXstream für die digitale Transformation in Lateinamerika | 240 | Die neue Lösung hilft Gulf Oil, die Zusammenarbeit mit Vertriebspartnern zu modernisieren, langfristiges digitales Wachstum zu unterstützen und ein einheitliches Kundenerlebnis auf SAP S/4HANA zu... ► Artikel lesen | ||
| Di | 78% of French Food Manufacturers Now Factor Yuka Scores Into Product Formulation | 184 | New IFOP study demonstrates measurable impact of consumer transparency tools on food industry practices
A new study from France's oldest and most reputable polling organization, IFOP, reveals the... ► Artikel lesen | ||
| Di | Alcon Announces Amended Merger Agreement with STAAR Surgical | 214 | Agreement follows discussions with STAAR stockholders and the closure of STAAR's "go-shop" period New terms include an increase in acquisition price and reductions in payments to executives... ► Artikel lesen | ||
| Di | DataXstream LLC: Gulf Oil Selects DataXstream's OMS+ Portal to Power LATAM Digital Transformation | 273 | New deployment will enable Gulf Oil to modernize the distributor experience, support long-term digital growth and deliver a unified customer experience on SAP S/4HANA
DataXstream LLC, an SAP Endorsed... ► Artikel lesen | ||
| Di | Finance Leaders Anticipate Rising Volatility but Reveal Uneven Preparedness as 2026 Approaches, Alpha Group Research Finds | 173 | Senior finance leaders are preparing for a year of heightened foreign exchange volatility and liquidity pressure in 2026, yet many acknowledge their organisations are not fully equipped to manage... ► Artikel lesen | ||
| Di | BeOne Medicines Ltd.: BRUKINSA erzielt bahnbrechendes 6-Jahres-PFS von 74 % bei Patienten mit unbehandelter chronischer lymphozytischer Leukämie | 171 | Mehrere Follow-up-Langzeitstudien bestätigen die überlegene Wirksamkeit und gute Verträglichkeit von BRUKINSA verglichen mit Ibrutinib bei rezidivierter oder refraktärer CLL Ergänzende ASH-Daten... ► Artikel lesen | ||
| Di | Enterprise Therapeutics Ltd: Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis | 189 | ETD001 is well tolerated in healthy individuals at higher doses than predicted to be therapeutic for long-lasting enhancement of mucociliary clearance Results showed excellent consistency... ► Artikel lesen |